ImmunoCellular Therapeutics (IMUC) Reports LOI with Memgen for Joint Immuno-Oncology Collaboration
Tweet Send to a Friend
ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) and Memgen, LLC announce the signing of a non-binding letter of intent to exclusively negotiate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
